Skip to content
healthcare.dev
Get a free key

Doxazosin

NDC 16571-165, Doxazosin, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-165
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212727
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE1 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
16571-165-0116571016501100 TABLET in 1 BOTTLE (16571-165-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/508b908e-8d80-422e-8ec0-2081185f4c95

  • NADAC price for package 16571016501

    GET /v1/drugs/nadac/16571016501

Use it

Look up 16571-165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.